C39H67N5O7
718 g/mol
Farmasötik Ara MaddeTehlike
Monomethyl auristatin E
CAS474645-27-7
Kategori
Farmasötik Ara Madde
Bileşik Sınıfı
Peptit
Birincil Kullanım
Farmasötik ara ürün
Monomethyl auristatin E is a complex peptide-based compound used as a pharmaceutical intermediate in the manufacturing of antibody-drug conjugates. Its structure features multiple amide groups, an aromatic ring, and several chiral centers, contributing to its role as a key building block in targeted therapeutic development.
pharmaceutical intermediate for antibody-drug conjugate manufacturing
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 474645-27-7
İlgili Bileşikler
GüçlüBenzer yapıBenzerlik 0.87
L-Valinamide, N,N-dimethyl-L-valyl-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-hydro xy-1-methyl-
CAS160800-57-7
active pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.78
MMAF
CAS745017-94-1
pharmaceutical intermediate
BenzerBenzer yapıBenzerlik 0.73
Mc-MMAE
CAS863971-24-8
antibody-drug conjugate payload
UygulamaAynı kullanım
MC-Gly-Gly-Phe-Gly
CAS2413428-36-9
pharmaceutical intermediate for antibody-drug conjugate
UygulamaAynı kullanım
N-Acetyl calicheamicin
CAS108212-76-6
pharmaceutical intermediate for antibody-drug conjugate
ReferansAynı kategori
Hydronopol
CAS4747-61-9
Pharmaceutical intermediate for pivonium bromide
ReferansAynı kategori
Tert-Butyl 3,4-dihydroxypiperidine-1-carboxylate
CAS475062-48-7
Pharmaceutical intermediate
ReferansAynı kategori
(5-Bromo-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid
CAS475102-13-7
Pharmaceutical intermediate for synthesis
Güvenlik Referansı
Tehlike
H300Fatal if swallowed
H330Fatal if inhaled
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H340May cause genetic defects
H341Suspected of causing genetic defects
H360May damage fertility or the unborn child
H370Causes damage to organs
H372Causes damage to organs through prolonged or repeated exposure
H412Harmful to aquatic life with long lasting effects
Tanımlayıcılar
IUPAC Adı
(2S)-N-[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamide
InChIKey
DASWEROEPLKSEI-UIJRFTGLSA-N
SMILES
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC
Eş Anlamlılar (22)
- 4Q5
- MMAE
- MMAE peptide
- Monomethyl auristatin E
- Monomethyl auristatin E (GMP)
- [3H]-Vedotin